BIAF

Conviction 8HealthcareScan · Fri, Jun 26, 2026

BIAF$0.8451+0.57%

ResistanceSupportVol 14

Vol MA14 667.2K

Mar 27Apr 15May 4May 20Jun 9Jun 26

bioAffinity Technologies, Inc.SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCHwww.bioaffinitytech.com ↗

Price0.8451

Change+0.57%

Gap+0.65%

Rel volume0.29×

Avg volume540.79K

Avg $ vol567.07K

SMA 201.32

SMA 501.79

SMA 2001.94

Price vs 50-52.72%

Price vs 200-56.33%

MA stackbearish

50/200 crossdeath · 3d

Supertrenddown · 1.26

RSI (14)26

MACD hist-0.03

MACD crossbear · 7d

Stoch %K / %D7 / 6

ADX (14)19

+DI / −DI20 / 33

RSI divergence—

MACD divergence—

ATR %+19.30%

ADR %11.75%

52w high5.29

52w low0.1691

From 52w high-84.02%

Above 52w low+399.76%

New 52w highNo

SqueezeOff

Bollinger width119.88%

%B0.20

Donchian pos4.67%

Donchian high2.18

Donchian low0.7800

AVWAP (52w high)3.12

vs AVWAP high-72.90%

AVWAP (52w low)3.07

vs AVWAP low-72.51%

OBV trendDown

Chaikin MF (20)-0.32

Today vs 20d0.29×

Avg vol (14d)667.2K

Avg vol (20d)540.79K

Avg $ vol (20d)567.07K

Market cap—

RS 3m (vs SPY)-90.63%

RS 6m (vs SPY)-41.06%

RS line new highNo

Trend template2/8

Technical rank7.9

1 week+0.94%

1 month-48.78%

3 months-82.17%

6 months-31.29%

1 year+244.94%

YTD-30.73%

P/E-0.25

P/B1.04

P/S0.62

P/FCF-0.40

EPS-8.66

Div yield—

ROE-407.22%

ROA-187.66%

Debt/Eq0.03

Current1.36

EV/EBITDA—

Gross margin0.07%

Net margin-241.96%

Rev growth-34.18%

EPS growth-64.93%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value823.49K

Revenue1.35M

Net income-3.63M

Gross profit223.78K

Free cash flow-9.39M

IndustrySERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH

ExchangeNasdaq

Shares out4.53M

Employees57

ListedThu, Sep 1, 2022

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction8 / 100

Pattern quality—

Tech rank7.9 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.19

Support1.09

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in BIAF

All disclosures →

No recent disclosed trades by Congress in BIAF. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in BIAF

No recent insider (Form 4) filings in BIAF. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in BIAF · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.